Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2021 Oct 21;21(1):38–47. doi: 10.1158/1535-7163.MCT-21-0293

Table 1.

Median survival summary of all therapy groups in KPfC GEMM mice.

Data
Summary
Vehicle TP-
0903
Gem anti-
PD1
TP-0903
+Gem
TP-0903
+anti-PD1
Gem+anti-
PD1
TP-0903
+Gem+anti-PD1
Median survival 72 78 89.5 69.5 92.5 85 87.5 95.5
P value vs. Vehicle NA 0.19 0.0095 0.267 0.0016 0.06 (P=0.0041 vs. anti-PD1) 0.0082 0.0002 (P=0.08 vs. Gem)